Health Care: Drugs

Mylan Inc (MYL: NASDAQ)

$46.53 n/a | n/a%
09/22/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 6.91B 6.80B 6.13B 5.45B
Cost of Sales 3.35B 3.34B 3.06B 2.81B
Gross Operating Profit 3.56B 3.45B 3.07B 2.64B
Selling, General, and Administrative Expenses 1.41B 1.40B 1.21B 1.09B
Research & Development 507.82M 401.34M 294.73M 282.15M
Operating Income before D & A (EBITDA) 1.64B 1.65B 1.56B 1.27B
Depreciation & Amortization 516.00M 546.60M 510.69M 422.79M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -74.85M 6.56M -14.87M -34.18M
Special Income / Charges 14.64M 0.00 -48.56M -127.06M
Total Income Before Interest Expenses (EBIT) 1.06B 1.11B 990.58M 687.41M
Interest Expense 313.34M 308.70M 335.94M 331.46M
Pre-Tax Income 747.34M 804.08M 654.64M 355.94M
Income Taxes 120.81M 161.14M 115.83M 10.40M
Minority Interest 2.82M 2.08M 1.99M 427.00K
Net Income From Continuing Operations 626.53M 642.93M 538.80M 345.54M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 626.53M 642.93M 538.80M 345.54M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 623.71M 640.85M 536.81M 345.12M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
611.89M 642.93M 587.36M 472.60M
Preferred Dividends
Net Income Available To Common 626.53M 642.93M 538.80M 224.01M
Basic EPS from Continuing Ops. 1.63 1.54 1.25 0.69
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.63 1.54 1.25 0.69
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.63 1.54 1.25 0.69
Basic Normalized Net Income/Share 1.59 1.54 1.36 0.94
EPS fr Continuing Ops. 1.58 1.52 1.22 0.68
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.58 1.52 1.22 0.68
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.58 1.52 1.22 0.68
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.54 1.52 1.33 0.93
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with MYL

Latest MYL Headlines from TheStreet

More Financial News for MYL

Press Releases for MYL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter